Kelly Chibale

Last updated

Kelly Chibale
PhD, FRSSAf, FRSC
Born (1964-03-31) 31 March 1964 (age 60)
Zambia
Alma mater University of Cambridge
University of Zambia
Scientific career
Institutions University of Pennsylvania
University of Liverpool
Scripps Research Institute
Doctoral advisor Stuart Warren

Kelly Chibale PhD, MASSAf, FAAS, Fellow of UCT, FRSSAf, FRSC (born 1964) is professor of organic chemistry at the University of Cape Town, and the founder and director of H3D research center and H3D Foundation NPC. In 2018 he was recognised as one of Fortune magazine's top 50 World's Greatest Leaders. [1] [2] His research focuses on drug discovery and the development of tools and models to contribute to improving treatment outcomes in people of African descent or heritage.

Contents

Early life and education

Chibale grew up without electricity or running water in Muwele Village, Chief Chiundaponde, Mpika district, Zambia. [3] [4] His parents are Elizabeth Malekano Chanda and Harrison Chibale. [4] He studied chemistry at the University of Zambia, graduating in 1987. [5] Chibale worked at Kafironda Explosives in Mufulira. [4] As there were no opportunities for graduate studies in Zambia, he moved to the University of Cambridge for his PhD, working in Stuart Warren's group on synthetic organic chemistry of optically active molecules. [6] He was funded by a Cambridge Livingstone Trust scholarship. [6]

Research and career

Following his PhD, Chibale joined the University of Liverpool as a Sir William Ramsay British Postdoctoral Research Fellow. He developed optically active alcohols using lanthanides. In 1994 he joined the Scripps Research Institute, creating complicated natural and designed molecules from organic building blocks. He began to explore angiogenesis inhibitors, which can be used to stop cancer cells developing new blood vessels. Inspired by medicinal chemistry, Chibale returned to Africa in 1996. In 2002 he joined the University of California, San Francisco as a Sandler Foundation Sabbatical Fellow. He was promoted to the rank of  Professor in 2007 and a Life Fellow of the University of Cape Town in 2009. His group currently studies treatments for malaria, tuberculosis, and antibiotic-resistant microbial diseases. [7] He set up collaborations and exchange programs for South African students to learn how to translate basic science into potential products. [8] He was elected a Fellow of the Royal Society of South Africa in 2009. [9]

In 2010 he founded H3D, the first drug discovery centre of its kind in Africa, at the University of Cape Town. [1] [10] The research program received significant media attention and has been supported by Bill Gates. [3] In 2008 he took a sabbatical, working as a Fulbright scholar at the University of Pennsylvania and Pfizer. [6] In 2012 Chibale's group discovered MMV390048, an aminopyridine compound that can be used as a single-dose treatment for malaria. [11] [12] It was the first antimalarial medicine to enter phase 1 human studies in Africa. [13] In 2016 they discovered another antimalarial compound, UCT943. [14] [15] [13] He has written for The Conversation about how Africa's medicinal drug research can paved the landscape for health innovation in the continent. [16]

Today he holds the Neville Isdell Chair in African-centric Drug Discovery and Development at the University of Cape Town. [17] [18] Over the years H3D has partnered with the South African government and innovative pharmaceutical companies to build Africa's capacity for research. [3]

In 2016 the Royal Society of Chemistry recognised him as one of their 175 Faces of chemistry. [18] He was elected a Fellow of the Royal Society of Chemistry in 2014. [19]

Kelly has received many notable awards and honors, which include:

Kelly was also:

  1. one of the 100 Most Influential Africans by New African magazine for 2019
  2. one of the world’s top 60 most influential/ inspirational leaders in the pharmaceutical industry on The Medicine Maker's 2020 and 2021 Power Lists
  3. one of the 22 black biotech leaders in honour of Juneteenth in the USA in 2021. The list, published by the Timmerman Report, celebrates innovative black leaders who are change-makers in their respective fields;
  4. one of the 25 standout voices in African public health by Harvard University’s Public Health magazine, 12 May 2022
  5. the first Editor-In-Chief from Africa of an American Chemical Society (ACS) publication when appointed EIC of ACS Medicinal Chemistry Letters in 2023
  6. Awarded Royal Society (UK) Africa Prize 2023
  7. Awarded Schmidt Sciences AI2050 Senior Fellowship 2023, one of seven worldwide
  8. Awarded Honorary Doctorate of the Faculty of Science, University of Basel in 2023

Related Research Articles

<span class="mw-page-title-main">University of Cape Town</span> Public university in Cape Town, South Africa

The University of Cape Town (UCT) is a public research university in Cape Town, South Africa. Established in 1829 as the South African College, it was granted full university status in 1918, making it the oldest university in South Africa and the oldest university in Sub-Saharan Africa in continuous operation.

<span class="mw-page-title-main">Artemisinin</span> Group of drugs used against malaria

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Artemisinin-based combination therapies (ACTs) are now standard treatment worldwide for P. falciparum malaria as well as malaria due to other species of Plasmodium. Artemisinin is extracted from the plant Artemisia annua a herb employed in Chinese traditional medicine. A precursor compound can be produced using a genetically engineered yeast, which is much more efficient than using the plant.

<span class="mw-page-title-main">E. Neville Isdell</span>

Edward Neville Isdell is an Irish businessman, former chair and CEO of The Coca-Cola Company and currently president of the WWF.

Max Price served as the vice-chancellor and principal of the University of Cape Town (UCT) in South Africa, succeeding Njabulo Ndebele. He held this position for a decade, from 19 August 2008, until 30 June 2018.

<span class="mw-page-title-main">Harry Oppenheimer Fellowship Award</span>

The Harry Oppenheimer Fellowship Award is awarded annually by the Oppenheimer Memorial Trust. It is considered the top award for research on the African continent.

<span class="mw-page-title-main">Mamokgethi Phakeng</span> South African Mathematician and Research scientist

Rosina Mamokgethi Phakeng is a South African professor of mathematics education who in 2018 became a vice-chancellor of the University of Cape Town (UCT). She has been the vice principal of research and innovation, at the University of South Africa and acting executive dean of the College of Science, Engineering and Technology at UNISA. In 2018 she was an invited speaker at the International Congresses of Mathematicians. In February 2023 it was announced that she would leave her position as vice-chancellor of UCT and take early retirement. She was succeeded by Professor Daya Reddy on 13 March 2023

Jean-François Rossignol is a French scientist, a medicinal chemist and a physician, born in France on September 5, 1943. He was educated at the University of Paris, later specializing in tropical medicine. He then pursued a career in academia and in the pharmaceutical industry discovering and developing new drugs for the treatment of parasitic diseases such as halofantrine in the treatment of multidrug resistant Falciparum malaria or albendazole and nitazoxanide for the treatment of intestinal protozoan and helminthic infections. In 1993, he co-created his own pharmaceutical company, Romark Laboratories, L.C., to develop his own invention nitazoxanide, the first of the thiazolides. At Romark, he is the Chairman of the Board of Directors of the company and its Chief Science Officer. Following the discovery of the antiviral activity of the thiazolides Rossignol went to Stanford University in California to study interferon stimulated gene pathways and chronic viral hepatitis under Prof. Emmet Keeffe and Prof. Jeffery Glenn. It was in the Glenn laboratory that the mechanism of antiviral activity of nitazoxanide against the hepatitis C virus was discovered.

Graham John Hutchings CBE FRS FIChemE FRSC FLSW is a British chemist, Professor for Research at Cardiff University.

<span class="mw-page-title-main">University of Cape Town Libraries</span> Library system of the University of Cape Town

University of Cape Town Libraries is the library system of the University of Cape Town in Cape Town, South Africa.

Ivan Addae-Mensah, is a Ghanaian chemist and university administrator who served as the Vice-Chancellor of the University of Ghana, Legon from 1996 to 2002. He is an Emeritus Professor of Chemistry at the same institution. He is a Life Fellow of the Royal Society of Chemistry, Fellow of the Ghana Academy of Arts and Sciences and a Fellow of the Ghana Chemical Society.

Bongani Mawethu Mayosi BMedSci, MB ChB, FCP(SA), DPhil, was a South African professor of cardiology He was the Dean of the Faculty of Health Sciences at the University of Cape Town and an A-rated National Research Foundation researcher. Prior to this, he was head of the Department of Medicine at the University of Cape Town and Groote Schuur Hospital. his research interests included rheumatic fever, tuberculous pericarditis and cardiomyopathy. He was a member of the Academy of Science of South Africa and a former President of the College of Physicians of South Africa and he headed numerous other biomedical organisations during his career.

<span class="mw-page-title-main">John Parkington</span> South African archaeologist

John Parkington is an Emeritus professor in archaeology and hunter-gatherers, Paleoenvironmental reconstruction and human ecology, prehistoric art, and coastal archaeology. He has suggested that since fish provide an important nutrient for the brain, the consumption of fish led to the emergence of the first really intelligent humans in the Western Cape region of South Africa. In February 2000 South African President Thabo Mbeki mentioned the letter he had received from Parkington, regarding the protection of archaeological heritage sites, in his address at the opening of South Africa's Parliament.

Peggoty Mutai is a Kenyan chemist. Born in Kericho, her interests include medicinal chemistry, in particular working with the search for new treatments against parasitic worms.

Peter Dunsby is a full professor of gravitation and cosmology at the Department of Mathematics and Applied Mathematics at the University of Cape Town, South Africa. He was the co-director of the Astrophysics, Cosmology and Gravity Centre at the university until 2016. He also serves on the editorial board of the International Journal of Modern Physics.

<span class="mw-page-title-main">Abdoulaye Djimdé</span>

Abdoulaye Djimdé is an associate professor of Microbiology and Immunology in Mali. He works on the genetic epidemiology of antimalarial drug resistance and is a Wellcome Sanger Institute International Fellow. He is Chief of the Molecular Epidemiology and Drug Resistance Unit at the University of Bamako Malaria Research and Training Centre.

<span class="mw-page-title-main">Tolullah Oni</span> Nigerian urban epidemiologist

Tolullah "Tolu" Oni is a Nigerian urban epidemiologist at the Medical Research Council Epidemiology Unit at the University of Cambridge. She is a NextEinstein Forum Fellow and World Economic Forum Young Global Leader.

Matthew John Fuchter is a British chemist who is a Professor of Chemistry at Imperial College London. His research focuses on the development and application of novel functional molecular systems to a broad range of areas; from materials to medicine. He has been awarded both the Harrison-Meldola Memorial Prize (2014) and the Corday–Morgan Prizes (2021) of the Royal Society of Chemistry. In 2020 he was a finalist for the Blavatnik Awards for Young Scientists.

Eftyhia Vardas FC Path is an honorary extraordinary professor in medical virology at the Department of Medical Virology, University of Stellenbosch, and head of virology at Lancet Laboratories in Johannesburg. She is a member of the COVID-19 Ministerial Advisory Committee to the South African minister of health.

Carolyn Williamson is a South African virologist and microbiologist who is a professor of medical virology at the University of Cape Town. She is a fellow of the Royal Society of South Africa and the African Academy of Sciences, and a member of the Academy of Science of South Africa. Her research focuses on HIV vaccine development and prevention of the disease.

<span class="mw-page-title-main">Hulda Swai</span> Tanzanian researcher and professor

Hulda Shaidi Swai,, is a Tanzanian researcher and professor in life sciences and bioengineering. She is a pioneer in nanomedicine research in the development of drugs against infectious diseases in Africa. Her work focuses in particular on the use of nanotechnology in antimalarial drugs.

References

  1. 1 2 "The World's 50 Greatest Leaders". Fortune. Retrieved 26 May 2018.
  2. ↑ "Zambia : Zambian Professor named one of the 50 World's Greatest Leaders for 2018". LusakaTimes.com. 24 April 2018. Retrieved 26 May 2018.
  3. 1 2 3 Winks, Susan; Woodland, John G.; Pillai, Goonaseelan ‘Colin’; Chibale, Kelly (August 2022). "Fostering drug discovery and development in Africa". Nature Medicine. 28 (8): 1523–1526. doi:10.1038/s41591-022-01885-1. PMID   35840729.
  4. 1 2 3 "Inspiring life of Prof Chibale – Zambia Daily Mail". www.daily-mail.co.zm. Retrieved 26 May 2018.
  5. ↑ "Prof Kelly Chibale | Department of Chemistry". www.chemistry.uct.ac.za. Retrieved 26 May 2018.
  6. 1 2 3 Leonard, Jenny (25 October 2012). "Kelly Chibale: An advocate of innovation". South African Journal of Science. 108 (11/12). doi: 10.4102/sajs.v108i11/12.1453 .
  7. ↑ "Learn more".
  8. ↑ Jarvis, Lisa M. "Building Brick By Brick | May 4, 2009 Issue - Vol. 87 Issue 18 | Chemical & Engineering News". cen.acs.org. Retrieved 26 May 2018.
  9. ↑ "AfOx insaka – with Prof Kelly Chibale and Prof Sandra Fredman » Africa Oxford Initiative". www.afox.ox.ac.uk. Retrieved 27 May 2018.
  10. ↑ SciDev.Net. "Africa gets 'holistic' drug discovery centre". SciDev.Net. Retrieved 26 May 2018.
  11. ↑ "Malaria about to be stung". News24. Retrieved 26 May 2018.
  12. ↑ "MMV048 | Medicines for Malaria Venture". www.mmv.org. Retrieved 26 May 2018.
  13. 1 2 "FIVE QUESTIONS WITH PROF. KELLY CHIBALE | Drug Discovery and Development Centre (H3D)". www.h3d.uct.ac.za. Retrieved 26 May 2018.
  14. ↑ "University of Cape Town's H3-D makes advances in malaria eradication". CPAfrica. 7 December 2017. Retrieved 26 May 2018.
  15. ↑ Editor, Online (3 August 2016). "Second potent anti-malarial candidate identified | Lusaka Voice". www.lusakavoice.com. Retrieved 26 May 2018.{{cite web}}: |last= has generic name (help)
  16. ↑ Chibale, Kelly. "How Africa is helping expand the global antimalarial drug pipeline". The Conversation. Retrieved 26 May 2018.
  17. ↑ "Professor Kelly Chibale PhD (Cambridge) FRSSAf FRSC | Infectious Disease & Molecular Medicine". www.idm.uct.ac.za. Retrieved 26 May 2018.
  18. 1 2 "Professor Kelly Chibale FRSC | 175 Faces of Chemistry". www.rsc.org. Archived from the original on 29 September 2020. Retrieved 26 May 2018.
  19. ↑ "Our Team | Drug Discovery and Development Centre (H3D)". www.h3d.uct.ac.za. Retrieved 26 May 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.